CYSTIC FIBROSIS
Clinical trials for CYSTIC FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new CYSTIC FIBROSIS trials appear
Sign up with your email to follow new studies for CYSTIC FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cystic fibrosis drug trial halted: what we know so far
Disease control TerminatedThis study tested a drug called (R)-Roscovitine in adults with cystic fibrosis who have a specific gene mutation (F508del) and a chronic lung infection. The goal was to see if the drug is safe and can reduce bacteria in the lungs. The trial was stopped early, so results are limit…
Matched conditions: CYSTIC FIBROSIS
Phase: PHASE2 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
CF drug combo trial halted early – did it work?
Disease control TerminatedThis early-stage trial tested whether adding glycerol phenylbutyrate (Ravicti) to standard pancreatic enzyme therapy could improve chloride transport in the nasal cells of adults with cystic fibrosis. Only 16 people enrolled, and the study was terminated before completion. The go…
Matched conditions: CYSTIC FIBROSIS
Phase: PHASE1, PHASE2 • Sponsor: National Jewish Health • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Gene therapy inhaler tested for cystic fibrosis – study halted early
Disease control TerminatedThis study tested a single dose of an inhaled gene therapy (BI 3720931) in adults with cystic fibrosis who cannot use standard CFTR modulator drugs. The goal was to see if it was safe and could improve lung function. The trial was terminated early after enrolling only 5 participa…
Matched conditions: CYSTIC FIBROSIS
Phase: PHASE1, PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Can growth hormone help cystic fibrosis patients regain weight?
Symptom relief TerminatedThis early-stage study tested whether growth hormone can help adults with cystic fibrosis who are underweight gain weight and muscle. The goal was to improve nutrition, strength, and quality of life. Only 5 people were enrolled before the study was stopped early.
Matched conditions: CYSTIC FIBROSIS
Phase: PHASE1 • Sponsor: University of Massachusetts, Worcester • Aim: Symptom relief
Last updated May 18, 2026 12:04 UTC
-
Cystic fibrosis gene repair shows promise in lab, study halted early
Knowledge-focused TerminatedThis study aimed to see if special molecules called oligonucleotide blockers could fix a common genetic problem in cystic fibrosis. Researchers took cells from 16 patients with CFTR gene mutations and tested the blockers in the lab. The goal was to restore the missing protein and…
Matched conditions: CYSTIC FIBROSIS
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated May 26, 2026 07:01 UTC
-
Cystic fibrosis study aims to unlock disease secrets
Knowledge-focused TerminatedThis study collected blood, tissue, and medical information from people with cystic fibrosis and their families. The goal was to build a database for future research on how the disease progresses and its genetic causes. About 79 participants aged 4 and older took part. The study …
Matched conditions: CYSTIC FIBROSIS
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 26, 2026 06:49 UTC
-
AI listens to lungs: new study analyzes breathing sounds in chronic lung diseases
Knowledge-focused TerminatedThis study tested whether an electronic stethoscope combined with artificial intelligence could detect and classify abnormal lung sounds in people with cystic fibrosis, COPD, or pulmonary fibrosis. Researchers recorded lung sounds during routine checkups and used AI to identify p…
Matched conditions: CYSTIC FIBROSIS
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated May 26, 2026 06:45 UTC
-
Cystic fibrosis infection study seeks answers on rare bacteria
Knowledge-focused TerminatedThis study aimed to find out how common non-tuberculous mycobacteria (NTM) infections are in people with cystic fibrosis in France. Researchers collected sputum samples and blood tests from 848 patients to compare culture and serology methods. The study was terminated early, but …
Matched conditions: CYSTIC FIBROSIS
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC